Call for tenders Supplies
Rituximab
Notice published in French. The AI analysis summarises it for you in your language.
Tenders due closed — 4 March 2026 at 12:25
- Public buyer
- Cliniques universitaires Saint Luc
Woluwe-Saint-Lambert - Place of performance
- 1200 Woluwe-Saint-Lambert, Brussels-Capital
not published: buyer's address - Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 28 January 2026
- Notice language
- French
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Le marché concerne les fournitures de la spécialité pharmaceutique contenant le principe actif « Rituximab » en solution à diluer pour perfusion par voie intraveineuse (dosage : 500mg).
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33652100
Winning prices for comparable contracts
- A quarter below
- €290,000
- Median
- €403,000
- A quarter above
- €1,351,075
Amounts awarded (excl. VAT) over the last 3 years for 5 contracts in the same CPV group (3365…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Likely competitors: who wins with this buyer in this field
- Celltrion Healthcare Netherlands B.V. · 4 contracts won
- Medtronic Belgium S.A. · 2 contracts won
- PL Healthcare SA · 2 contracts won
- Viatris BV SRL · 2 contracts won
- CSL BEHRING · 1 contract won
Partners and subcontractors
Contract too big or too broad for you alone? Bid as a temporary consortium, or offer your services as a subcontractor.
Create your free account to see who is looking for a partner on this contract, and to register.
Companies winning this type of contract in the region
- Celltrion Healthcare Netherlands B.V. · 3 contracts won in 3 years
- CSL BEHRING · 1 contract won in 3 years
- EG · 1 contract won in 3 years
- MSD Animal Health · 1 contract won in 3 years
- Arega Pharma BVBA · 1 contract won in 3 years
- Aurobindo SA · 1 contract won in 3 years
- Laboratoires Delbert SAS · 1 contract won in 3 years
- Pfizer SA · 1 contract won in 3 years
Possible partners for a temporary consortium or subcontracting… and competitors worth knowing.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Immunoglobuline humaine normale pour administration intraveineuse Cliniques universitaires Saint Luc · 22 October 2026 |
CSL BEHRING | €16,277,080 |
| Rituximab Cliniques universitaires Saint Luc · 19 August 2026 |
Celltrion Healthcare Netherlands B.V. | €628,800 |
| Infliximab Cliniques universitaires Saint Luc · 19 August 2026 |
Celltrion Healthcare Netherlands B.V. | €2,492,000 |
| Bévacizumab Cliniques universitaires Saint Luc · 7 July 2026 |
Celltrion Healthcare Netherlands B.V. | €503,440 |
| Pomalidomide Cliniques universitaires Saint Luc · 19 May 2026 |
EG | €268,870 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 61901-2026.